首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1623篇
  免费   81篇
  国内免费   56篇
耳鼻咽喉   3篇
儿科学   76篇
妇产科学   15篇
基础医学   195篇
口腔科学   29篇
临床医学   179篇
内科学   442篇
皮肤病学   61篇
神经病学   103篇
特种医学   302篇
外科学   103篇
综合类   27篇
预防医学   69篇
眼科学   6篇
药学   82篇
中国医学   3篇
肿瘤学   65篇
  2023年   10篇
  2022年   5篇
  2021年   23篇
  2020年   13篇
  2019年   28篇
  2018年   34篇
  2017年   8篇
  2016年   11篇
  2015年   24篇
  2014年   26篇
  2013年   54篇
  2012年   49篇
  2011年   39篇
  2010年   60篇
  2009年   74篇
  2008年   48篇
  2007年   74篇
  2006年   46篇
  2005年   43篇
  2004年   33篇
  2003年   36篇
  2002年   30篇
  2001年   30篇
  2000年   29篇
  1999年   33篇
  1998年   77篇
  1997年   88篇
  1996年   106篇
  1995年   64篇
  1994年   59篇
  1993年   53篇
  1992年   25篇
  1991年   26篇
  1990年   31篇
  1989年   44篇
  1988年   43篇
  1987年   42篇
  1986年   55篇
  1985年   43篇
  1984年   10篇
  1983年   15篇
  1982年   14篇
  1981年   10篇
  1980年   13篇
  1979年   8篇
  1978年   14篇
  1977年   11篇
  1976年   14篇
  1975年   13篇
  1974年   6篇
排序方式: 共有1760条查询结果,搜索用时 31 毫秒
1.
2.
3.
4.
5.
6.
7.
8.
BACKGROUND: Since 1997, a number of trials have shown promising results in treating generalized vitiligo with narrowband ultraviolet B (UVB) both in adults and children. However, there is little knowledge concerning the duration and permanency of the treatment-induced repigmentation. OBJECTIVE: Our main objective was to perform a follow-up trial of successfully treated patients receiving narrowband UVB for generalized vitiligo. METHODS: We have investigated to what degree the treatment-induced repigmentation remains stable for up to 2 years post-treatment. We performed an initial open trial including 31 patients with generalized vitiligo. They received narrowband UVB thrice weekly for up to 12 months. Patients experiencing > 75% repigmentation were defined responders and were included in the follow-up trial. Responders were followed every 6 months for up to 2 years after cessation of treatment. We observed the pigmentation status and registered any changes indicating loss of pigmentation and relapse. RESULTS: Eleven of the 31 treated patients were included in the follow-up trial. Six patients had relapse and five patients had stable response 24 months after cessation of treatment. Four out of six relapses were within 6 months post-treatment. CONCLUSION: In our study population of 31 patients with generalized vitiligo, five patients (16%) experienced > 75% stable repigmentation 2 years after cessation of a treatment programme of up to 1 years narrowband UVB therapy.  相似文献   
9.
We report two clinical pregnancies occurring after intracytoplasmic sperm injection (ICSI) using cryopreserved spermatozoa obtained from testicular biopsy, made in two different infertility situations in our clinic. The first patient showed a secretory azoospermia associated with elevated serum follicular stimulating hormone (FSH) level and spermiogenesis maturation arrest. The second patient was affected by azoospermia resulting from bilateral epididymal obstruction. Spermatozoa present in the wet preparation of testicular biopsy made on the day of scrotal exploration were cryopreserved within the testicular tissue for both men. Intracytoplasmic injections were performed at a later date, using spermatozoa prepared from frozen-thawed tissues. In each case, three embryos were obtained and transferred in utero. The transfers resulted in a twin pregnancy for the first case, and in a singleton pregnancy for the second. Living foetuses were seen in the ultrasound scan at the 7th week and both pregnancies are proceeding to date beyond 30 weeks without complications.   相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号